Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATR | Q13535 | 1/20 | 0.43 |
| ▸ | BRD9 | Q9H8M2 | 1/20 | 0.39 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.39 |
| ▸ | AAK1 | Q2M2I8 | 2/20 | 0.39 |
| ▸ | LCK | P06239 | 4/20 | 0.39 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | METAP1 | P53582 | 1/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
| ▸ | BRD4 | O60885 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16879643 | 0.86 | ATR (0.44) | ATRBRD9P2RX3AAK1LCK | |
| SCHEMBL17336445 | 0.85 | AAK1 (0.44) | ATRBRD9AAK1LCKCA12 | |
| SCHEMBL29948300 | 0.84 | CYP17A1 (0.46) | ATRP2RX3AAK1MAPKAPK2METAP1 | |
| SCHEMBL18369794 | 0.84 | ATR (0.42) | ATRBRD9P2RX3AAK1MAPKAPK2 | |
| SCHEMBL1970778 | 0.84 | CYP17A1 (0.46) | ATRP2RX3AAK1MAPKAPK2METAP1 | |
| SCHEMBL17336530 | 0.84 | AAK1 (0.42) | ATRBRD9P2RX3AAK1LCK | |
| SCHEMBL29364468 | 0.84 | ATR (0.42) | ATRBRD9P2RX3AAK1MAPKAPK2 | |
| SCHEMBL1581324 | 0.84 | ATR (0.42) | ATRBRD9P2RX3AAK1MAPKAPK2 | |
| SCHEMBL12584018 | 0.84 | MAPKAPK2 (0.43) | ATRP2RX3AAK1MAPKAPK2METAP1 | |
| SCHEMBL21262226 | 0.83 | ATR (0.44) | ATRBRD9P2RX3AAK1LCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022076975-A1 | 5- AND 6-AZAINDOLE COMPOUNDS FOR INHIBITION OF BCR-ABL TYROSINE KINASES | ENLIVEN THERAPEUTICS, INC. (US) | 2022-04-14 | — | — | WO | disclosed |
| EP-3689860-A1 | SULFONYL-SUBSTITUTED BICYCLIC COMPOUND WHICH ACTS AS ROR INHIBITOR | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) | 2020-08-05 | — | — | EP | disclosed |
| US-10011568-B2 | Cyclohexyl pyridine derivative | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2018-07-03 | — | — | US | disclosed |
| US-20170298024-A1 | CYCLOHEXYL PYRIDINE DERIVATIVE | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2017-10-19 | — | — | US | disclosed |
| US-9708266-B2 | Cyclohexyl pyridine derivative | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2017-07-18 | — | — | US | disclosed |
| US-20170057920-A1 | CYCLOHEXYL PYRIDINE DERIVATIVE | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2017-03-02 | — | — | US | disclosed |
| US-20160289206-A1 | CARBOXYMETHYL PIPERIDINE DERIVATIVE | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2016-10-06 | — | — | US | disclosed |
| US-8426450-B1 | Substituted 4-phenyl pyridines having anti-emetic effect | HELSINN HEALTHCARE SA (CH) | 2013-04-23 | — | — | US | disclosed |
| US-8404708-B2 | Dual NK1/NK3 receptor antagonists | HOFFMANN-LA ROCHE INC. (US) | 2013-03-26 | — | — | US | disclosed |
| US-8247431-B2 | Heterocyclic hydrazide compound and pesticidal use of the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-08-21 | — | — | US | disclosed |
| US-8247431-B2 | Heterocyclic hydrazide compound and pesticidal use of the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-08-21 | — | — | US | disclosed |
| EP-2144898-B1 | HETEROCYCLIC HYDRAZIDE COMPOUND AND PESTICIDAL USE OF THE SAME | SUMITOMO CHEMICAL CO (JP) | 2012-02-08 | — | — | EP | disclosed |
| EP-2144898-B1 | HETEROCYCLIC HYDRAZIDE COMPOUND AND PESTICIDAL USE OF THE SAME | SUMITOMO CHEMICAL CO (JP) | 2012-02-08 | — | — | EP | disclosed |
| US-20110178055-A1 | DUAL NK1/NK3 RECEPTOR ANTAGONISTS | HOFFMANN TORSTEN | 2011-07-21 | — | — | US | disclosed |
| US-20100137362-A1 | HETEROCYCLIC HYDRAZIDE COMPOUND AND PESTICIDAL USE OF THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-06-03 | — | — | US | disclosed |
| US-20100137362-A1 | HETEROCYCLIC HYDRAZIDE COMPOUND AND PESTICIDAL USE OF THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-06-03 | — | — | US | disclosed |
| EP-2144898-A2 | HETEROCYCLIC HYDRAZIDE COMPOUND AND PESTICIDAL USE OF THE SAME | Sumitomo Chemical Company, Limited (JP) | 2010-01-20 | — | — | EP | disclosed |
| WO-2008130021-A2 | HETEROCYCLIC HYDRAZIDE COMPOUND AND PESTICIDAL USE OF THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-10-30 | — | — | WO | disclosed |
| WO-2008130021-A2 | HETEROCYCLIC HYDRAZIDE COMPOUND AND PESTICIDAL USE OF THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-10-30 | — | — | WO | disclosed |
| EP-1643998-B1 | DUAL NK1/NK3 ANTAGONISTS FOR TREATING SCHIZOPHRENIA | HOFFMANN LA ROCHE (CH) | 2007-08-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110178055-A1 | DUAL NK1/NK3 RECEPTOR ANTAGONISTS | TACR2, TAC3, TACR1 | ATR 4649/4885BRD9 3289/4885P2RX3 220/4885 |
| US-20170298024-A1 | CYCLOHEXYL PYRIDINE DERIVATIVE | CYP3A43, CYP3A5, CYP3A4 | ATR 2723/4885BRD9 3068/4885P2RX3 79/4885 |
| US-10011568-B2 | Cyclohexyl pyridine derivative | CYP3A43, CYP3A5, CYP3A4 | ATR 2723/4885BRD9 3068/4885P2RX3 79/4885 |
| US-20100137362-A1 | HETEROCYCLIC HYDRAZIDE COMPOUND AND PESTICIDAL USE OF THE SAME | ACHE, CAT, DNPH1 | ATR 3515/4885BRD9 1859/4885P2RX3 1265/4885 |
| US-20160289206-A1 | CARBOXYMETHYL PIPERIDINE DERIVATIVE | TACR1, CYP3A5, CNR1 | ATR 2414/4885BRD9 1517/4885P2RX3 80/4885 |
| US-20170057920-A1 | CYCLOHEXYL PYRIDINE DERIVATIVE | CYP3A43, CYP3A5, CYP3A4 | ATR 2742/4885BRD9 3058/4885P2RX3 82/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.